Abstract:In the past three decades significant strides have been made in attempts at nonparenteral immunization. Appreciation of the importance of secretory immunity led to attempts to stimulate antibody production locally. The vaccines developed against respiratory pathogens as a result of this new knowledge have many practical limitations, such as the need for highly trained personnel, expensive equipment, very cooperative recipients for intranasal or aerosol administration, and a vaccine that is both adequately attenuated, immunogenic, and stable during storage. With recognition of the presence of a common mucosal defense system, new approaches to vaccine development have become possible. Oral immunization, by stimulating GALT, presents a promising approach for protecting many secretory surfaces against a variety of infectious agents. Recently, emphasis has been placed on developing an oral vaccine against S. mutans. McGhee et al. have demonstrated antibody to S. mutans in saliva and tears following oral ingestion of that antigen, without a rise in serum antibody, in both humans and rats. The rats were afforded protection from caries after rechallenge with both the original and cross-reacting serotypes of S. mutans. Similar results have recently been seen with viral antigens. Mice have been shown to have significant protection against influenza infection following oral immunization. And in a pilot study with human volunteers, the secretory antibody response in nasal washes was similar following either oral or parenteral vaccination. Oral immunization may prove to be far superior to parenteral vaccination against a variety of pathogens, because of fewer side effects and greater ease in vaccine preparation and administration.

Electron-paramagnetic-resonance investigation of the iron-indium pair in silicon.

Formulation technologies for oral vaccines

Delivery strategies to enhance oral vaccination against enteric infections

Oral Vaccines: A Better Future of Immunization

Recent development of oral vaccines (Review)

Oral Vaccine Delivery for Intestinal Immunity—Biological Basis, Barriers, Delivery System, and M Cell Targeting

Cutting-edge research frontiers in oral cavity vaccines for respiratory diseases: a roadmap for scientific advancement

A guide to oral vaccination: Highlighting electrospraying as a promising manufacturing technique toward a successful oral vaccine development

Mucoadhesive Vaccine Delivery Systems for the Oral Mucosa

Challenges and opportunities in current vaccine technology and administration: A comprehensive survey examining oral vaccine potential in the United States

ORAL ROUTE AS METHOD FOR IMMUNIZING AGAINST MUCOSAL PATHOGENS

Vaccine Strategies to Elicit Mucosal Immunity

Nano and Microparticles as Potential Oral Vaccine Carriers and Adjuvants Against Infectious Diseases

Biomaterial Approaches for Understanding and Overcoming Immunological Barriers to Effective Oral Vaccinations

Modified ID-Based Threshold Decryption and Its Application to Mediated ID-Based Encryption

Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine

Oral cholera vaccines; current perspective and future need; towards the development of Novel DNA vaccine for Vibrio species.

Intranasal and oral vaccination with protein-based antigens: advantages, challenges and formulation strategies

Lessons learnt from 12 oral cholera vaccine campaigns in resource-poor settings

Oral vaccination against enteric bacterial infections: An overview